Antiretroviral treatment in HIV-infected children who require a rifamycin-containing regimen for tuberculosis-Reference-Cited by-同舟云学术

Antiretroviral treatment in HIV-infected children who require a rifamycin-containing regimen for tuberculosis

Published:2017-03-27 Issue:6 Volume:18 Page:589-598
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Rabie Helena¹²,Decloedt Eric H.³,Garcia-Prats Anthony J.⁴,Cotton Mark F.¹²,Frigati Lisa¹²,Lallemant Marc⁵,Hesseling Anneke⁴,Schaaf H. Simon¹⁴

Affiliation:

1. Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa

2. Children’s Infectious Diseases Clinical Research Unit, Stellenbosch University, Cape Town, South Africa

3. Division of Clinical Pharmacology, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa

4. Desmond Tutu TB Centre, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa

5. Pediatric HIV Program, Drugs for Neglected Diseases Initiative, Geneva, Switzerland

Funder

National Research Foundation

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2017.1309023

Reference95 articles.

1. Challenges in the Elimination of Pediatric HIV-1 Infection

2. Tuberculosis and HIV co-infection in children

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Outcomes in Children With Human Immunodeficiency Virus Treated for Nonsevere Tuberculosis in the SHINE Trial;Clinical Infectious Diseases;2024-04-09

2. Survival status and risk factors for mortality among multidrug-resistant tuberculosis patients in Addis Ababa, Ethiopia: A retrospective follow-up study;Journal of Clinical Tuberculosis and Other Mycobacterial Diseases;2023-12

3. Inadequate Lopinavir Concentrations With Modified 8-Hourly Lopinavir/Ritonavir 4:1 Dosing During Rifampicin-based Tuberculosis Treatment in Children Living With HIV;Pediatric Infectious Disease Journal;2023-07-20

4. Leveraging physiologically based pharmacokinetic modeling to optimize dosing for lopinavir/ritonavir with rifampin in pediatric patients;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2022-06-08

5. Childhood Tuberculosis;Essential Tuberculosis;2021